DYN

Conviction 92HealthcareScan · Mon, Aug 10, 2026

DYN$26.49+0.91%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 3.37M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Dyne Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.dyne-tx.com ↗

Price26.49

Change+0.91%

Gap-1.71%

Rel volume2.40×

Avg volume2.89M

Avg $ vol71.43M

SMA 2024.83

SMA 5022.05

SMA 20019.40

Price vs 50+20.11%

Price vs 200+36.58%

MA stackbullish

50/200 cross—

Supertrendup · 22.37

RSI (14)67

MACD hist-0.01

MACD crossbear · 2d

Stoch %K / %D89 / 84

ADX (14)25

+DI / −DI26 / 16

RSI divergence—

MACD divergenceBearish

ATR %+4.97%

ADR %5.52%

52w high26.49

52w low11.16

From 52w high+0.00%

Above 52w low+137.37%

New 52w highYes

SqueezeOff

Bollinger width18.35%

%B0.86

Donchian pos89.67%

Donchian high27.09

Donchian low21.28

AVWAP (52w high)26.24

vs AVWAP high+0.96%

AVWAP (52w low)18.53

vs AVWAP low+42.95%

OBV trendUp

Chaikin MF (20)0.37

Today vs 20d2.40×

Avg vol (14d)3.37M

Avg vol (20d)2.89M

Avg $ vol (20d)71.43M

Market cap4.95B

RS 3m (vs SPY)+43.96%

RS 6m (vs SPY)+44.50%

RS line new highNo

Trend template6/8

Technical rank90.2

1 week+4.95%

1 month+13.11%

3 months+50.43%

6 months+57.68%

1 year+136.73%

YTD+43.19%

P/E-11.09

P/B7.05

P/S—

P/FCF-12.21

EPS-3.47

Div yield—

ROE-63.55%

ROA-44.89%

Debt/Eq0.01

Current12.02

EV/EBITDA-9.18

Gross margin—

Net margin—

Rev growth—

EPS growth-40.58%

Price target40.27

Target upside52.02%

Analyst ratingBuy

Institutional108.39%

Ent. value4.28B

Revenue—

Net income-178.56M

Gross profit—

Free cash flow-405.13M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out165.31M

Employees258

ListedThu, Sep 17, 2020

Free float148.8M

Float %90.1%

Short interest21.49M

Days to cover10.6d

Short volume58.0%

Squeeze score81 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.08 vs −$0.74

Last surprise-46.0% miss

Setup gradeA+

Conviction92 / 100

Pattern quality—

Tech rank90.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance26.68

Support19.46

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DYN

All disclosures →

No recent disclosed trades by Congress in DYN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DYN · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	49.19K	$1.1M	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	11.66K	$276K	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	5K	$118K	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	124.38K	$2.9M	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	29.59K	$699K	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	62.54K	$1.4M	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-07	Sell	14.84K	$351K	2026-07-07	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-06	Sell	253.04K	$5.8M	2026-07-06	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-06	Sell	127.18K	$2.9M	2026-07-06	2026-07-08
Rhodes Jason P Director · Common Stock · 2026-07-06	Sell	100.02K	$2.3M	2026-07-06	2026-07-08

SEC filings

EDGAR filings in DYN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.